IL6 and acute respiratory distress syndrome: miR-26a-5p can inhibit the expression of inflammatory factors (TNF-α, IL-1β, and IL-6) and pro-apoptotic protein Bax, reduce pulmonary inflammation and apoptosis in mice, improve pulmonary inflammation and apoptosis, and increase the survival rate of septic ALI mice by 30% [70].